# The Voice as a Tool to Detect Recurrence of Laryngeal and Hypopharyngeal Cancer

> **NCT05894070** · — · RECRUITING · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 100 (estimated)

## Conditions studied

- Laryngeal Cancer
- Hypopharyngeal Cancer

## Interventions

- **OTHER:** Voice recording, ENT (Ear, Nose and Throat) examination including transnasal fiberendoscopy, and VHI-30-questionnaire

## Key facts

- **NCT ID:** NCT05894070
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-02
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05894070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05894070, "The Voice as a Tool to Detect Recurrence of Laryngeal and Hypopharyngeal Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05894070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*